Home Managed Care magazine Pharmscope Daily Briefing Formulary Kits Continuing Education QUIK Reports Resources Drug Database P&T Journal Home
Login / Register
Announcements
Use of Biologics in Immunotherapy
This seminar is designed to assist payers, employers, insurers, human resource administrators, and patient advocates to further their understanding of the science behind biologics while exploring strategies to optimize coverage and benefit design.

The seminars will be held from 9:00 am to 3:00 pm on: May 16, 2008 in Chicago and June 16, 2008 in Philadelphia

To register, please contact Emily Frelick via e-mail or via phone at (215) 955-8801.

View the new Formulary Kits for Abraxane, Bystolic, Fosrenol, Gelclair, Lialda, and Vyvanse.

 
David Nash, M.D, M.B.A., Editor in Chief
David Nash is The Dr. Raymond C. and Doris N. Grandon Professor and Chairman of the Department of Health Policy at Jefferson Medical College of Thomas Jefferson University in Philadelphia. From 1996 to 2003, he served as the first Associate Dean for Health Policy at Jefferson Medical College. In 2004, he was named Co-director of the Masters Program in Public Health at Jefferson.

Call For Papers
P&T Journal is now accepting article submissions from its readers. We welcome a wide variety of manuscripts, including drug class reviews, disease state management reviews, pharmacoeconomic analyses, outcomes research evaluations, DUEs, P&T committee experiences, commentaries, book reviews, and letters to the editor. Please see our author guidelines below or contact the editor, Sonja Sherritze, via phone 267-685-2779 or email: ssherritze@medimedia.com.

Guidelines For Authors

April 2008

Table of Contents

Highlights

COVER STORY:
Pharmacological Management of Sickle Cell Disease

MEDICATION ERRORS
Morphine and Hydromorphone: An Omnipresent Risk of Mix-ups

 

P&T Community

Update Your Registration Profile

Haven't received your weekly newsletters about the new features on PTcommunity.com? Check your newsletter status by clicking here. Scroll down to the question, 'Check here if you would like to receive our e-newsletter?' and choose 'Yes' or 'No.'
Having trouble with the site? Send an email.
 

PTcommunity.com is assembling an advisory board of formulary experts to provide editorial direction and content to the Web site. Experts from hospitals, managed care organizations, pharmaceutical industry, and the academic and private sectors will serve on the Advisory Board, playing integral roles in the evolution of PTcommunity.com. Contact Tony Berberabe, Senior Web Editor, for more information.

 
Resources
Drug Database: The Triple i Prescribing Guide

Pharmacy Policies/Procedures: Forms and guidelines

Cost Calculators: Exclusive online tools to evaluate your pharmacy costs

Links: A comprehensive map of web links to the world of managed care pharmacy

 
Pharmscope's Daily Briefing
News by category
• FDA Updates
• Drug Trials and Comparisons
• Managed Pharmacy Trends
• Legislation and Policy
• Foreign Drug Development
 
Subscribe to P&T Journal
Print Edition
  • Free to qualified professionals in the U.S.
  • Others may subscribe for $85/year U.S.; $120/year outside U.S.
Digital edition

  • Web-based
  • Free to all
  • All the words and pictures of the print edition
  • Searchable
  • Can be downloaded to read offline
Archive issues of P&T Journal:
 
Supplements focus on specific formulary issues that affect P&T decision makers. They often provide continuing education credit for physicians, pharmacists, and other health care providers.
Pharmacological Considerations In Acute Coronary Syndrome (ACS): An Expert Debate
Also available:

Self-Monitoring of Blood Glucose (SMBG): Considerations for Intensive Diabetes Management

Raising Expectations in the Management of Overactive Bladder with Urge Urinary Incontinence: Clinical and Economic Implications for Health Care Providers

Professional Collaboration Day: Synergy Through Collaboration Panel

Considerations in Creating a Medicare Part D Formulary
 
Introducing the Product Profiler, providing detailed information about a specific therapeutic agent to help manage formularies and establish medication-related policies.
Product Profiler: Revlimid
Product Profiler: Remicade
 


Visit Formkit.com to view the newest formulary kits, now available online:

Abraxane (paclitaxel protein-bound particles for injectable suspension) NEW FORMULARY KIT

Arimidex (anastrozole)

Bystolic (nebivolol) NEW FORMULARY KIT

Boniva (ibandronate sodium)

Campral (acamprosate calcium)

Eraxis (anidulafungin IV)

Faslodex (fulvestrant injection)

Fosrenol (lanthanum carbonate) NEW FORMULARY KIT

Gelclair (biadherent oral gel) NEW FORMULARY KIT

Lexapro (escitalopram oxalate)

Lialda (mesalamine) NEW FORMULARY KIT

Lucentis (ranibizumab injection)

Namenda (memantine HCl)

Nexium (esomeprazole magnesium)

Raptiva (efalizumab)

Revlimid (lenalidomide)

Tarceva (erlotinib) tablets

Tev-Tropin (somatropin, rDNA origin, for injection)

Veramyst (fluticasone furoate)
NEW FORMULARY KIT

Vyvanse (lisdexamfetamine dimesylate)
NEW FORMULARY KIT

Xolair (omalizumab)

 
 

PTCommunity.com provides its subscribers access to the P&T Digest series — peer-reviewed publications that provides pharmacists, physicians, and other health care providers who serve on pharmacy and therapeutics committees up-to-date information about the most efficacious and cost-effective medical treatments for a variety of illnesses.

Available now:
P&T Digest: Pain Management

P&T Digest: Asthma

P&T Digest: Depression

P&T Digest: Dry Eye Syndrome

P&T Digest: Hypertension

P&T Digest: Glaucoma

 
April 2008

Continuing Education Credit

Biologic Therapy Management: The Need For Value-Based Health Benefits Models


MediMedia USA
© 2008 MediMedia USA, Inc.
All Rights Reserved.